1.Sympathetic skin response in spinal cord injury patients.
Hee CHEONG ; Sei Il CHUN ; Chang Il PARK
Journal of the Korean Academy of Rehabilitation Medicine 1993;17(4):515-524
No abstract available.
Skin*
;
Spinal Cord Injuries*
;
Spinal Cord*
2.Invasive Aspergillosis On Lower Molar Periodontal Tissues: Case Report.
Il Kyu KIM ; Sei Young CHUN ; Sung Seop OH ; Jin Ho CHOI ; Keum Soo CHANG
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2002;28(1):81-85
This paper describes that invasive aspergillosis was found in oral cavity, especially in lower molar periodontium in a immunocompromised 34-year-old woman who had been admitted in hemato-oncology with the diagnosis of acute myeloid leukemia. Antifungal therapy and surgical excision of involved teeth, bone and gingiva were the treatment of choice. After treatment infected area was healed very well. We would like to report our case because we could not find any paper reporting on invasive aspergillosis occurring in lower molar periodontium.
Adult
;
Aspergillosis*
;
Diagnosis
;
Female
;
Gingiva
;
Humans
;
Leukemia, Myeloid, Acute
;
Molar*
;
Mouth
;
Periodontium
;
Tooth
3.Cathepsin D expression in the tumor cells and juxta-tumoral stromal cells of T1 invasive ductal carcinoma, Nos.
Baik Hyeon JO ; Doy Il KIM ; Won Hung LEE ; Tae Jin LEE ; Jae Hyung YOO ; Yee Kyung CHUN ; Yong Keum PARK ; In Taik CHANG ; Sei Ok YOON
Journal of Breast Cancer 2005;8(1):17-26
INTRODUCTION: Cathepsin D (CD) is a lysosomal protease that can be used as an important prognostic cytosolic factor for breast cancer. Its over-expression in breast cancer cells and in the host stromal cells in the tumor has been proposed as being a poor prognostic indicator. However, its prognostic value is still being debated. Therefore, CD expression needs to be examined in more relevant subsets of tissue in order to refine its prognostic significance and the clinical applications. METHODS: Regardless of the lymph node status, 110 T1 invasive ductal carcinomas of the breast were immunohistochemically evaluated for the CD expression using rabbit anti-cathepsin D monoclonal antibody. This study separately assessed the expression of CD in the invasive component (IDC), in the in situ component (DCIS), and in the juxtatumoral stromal cells (JTSC). The CD expression level in these three kinds of tissues were correlated with the nuclear grade, ER, PR, c-erb-B2, p53, the N stage, the T stage, and the 5 year metastasis-free survival. RESULTS: Positive CD expression in the JTSC was associated with the T stage (p = 0.001) and the N stage (p = 0.029), whereas positive CD expression in the DCIS and IDC was not. In addition, strong CD expression in the JTSC correlated with the nuclear grade of the invasive component (p = 0.024). In all three components, no statistically significant correlation was found between the biomarker (ER, PR, cerb-B2, p53) and the CD expression. On univariate analysis, positive expression in the JTSC was correlated with a poor 5 year- metastasis free survival (p = 0.007), but the positive expression in the IDC and DCIS was not. CONCLUSION: CD expression of the JTSC could represent the N stage, the T stage, and the nuclear grade of T1 IDC. Whether or not it would have an independent influence on the prognosis of T1 IDC, CD expression in the JTSC is probably an indicator of the tumor virulence. CD expression in the JTSC will provide an important clue for the development of new CD targeted therapies, and it will serve as an important criterion for selecting the appropriate candidates for these future targeted therapies.
Breast
;
Breast Neoplasms
;
Carcinoma, Ductal*
;
Carcinoma, Intraductal, Noninfiltrating
;
Cathepsin D*
;
Cathepsins*
;
Cytosol
;
Lymph Nodes
;
Neoplasm Metastasis
;
Prognosis
;
Stromal Cells*
;
Virulence
4.Gasless Endoscopic Thyroidectomy via an Anterior Chest Wall Approach Using a Flap-Lifting System.
Young Up CHO ; Il Jae PARK ; Kyong Ho CHOI ; Sei Joong KIM ; Sun Keun CHOI ; Yoon Seok HUR ; Keon Young LEE ; Seung Ik AHN ; Kee Chun HONG ; Seok Hwan SHIN ; Kyung Rae KIM ; Ze Hong WOO
Yonsei Medical Journal 2007;48(3):480-487
PURPOSE: Endoscopic thyroidectomy (ET) requires a proper working space for adequate visualization of anatomical structures and proper instrument manipulation. The purpose of this prospective study was to estimate the feasibility and safety of ET using an anterior chest wall approach without gas insufflation. MATERIALS AND METHODS: The working space was created under a direct and endoscopic view through a 3-cm incision on the anterior chest wall. A retracting device was then inserted to establish the working space, and subsequent procedures were performed endoscopically. All data were reviewed using a prospective database. RESULTS: We performed 30 ETs in patients with benign thyroid tumors from December 2003 to December 2005. The procedures were completed successfully in 29 patients (mean operative time: 160.6 min; range: 90-345 min). One patient with ET was converted to open thyroidectomy secondary to substernal extension of the tumor. None of the patients developed permanent postoperative hypocalcemia or recurrent laryngeal nerve paralysis. Three patients exhibited some degree of transient recurrent laryngeal nerve palsy. CONCLUSION: These data suggest that gasless ET using an anterior chest wall approach is safe and feasible in selected patients for treating benign thyroid tumors. This technique may offer good operative working space when performed by surgeons with relatively low-volume ET practices.
Adult
;
Endoscopy/*methods
;
Female
;
Humans
;
Male
;
Middle Aged
;
Reproducibility of Results
;
Thyroid Neoplasms/pathology/surgery
;
Thyroidectomy/instrumentation/*methods
;
Treatment Outcome
5.New risk factors for thromboembolic complications in atrial fibrillation.
Cheon Yeong CHO ; Dae Ho JUNG ; Jum Suk KO ; Nam Sik YOON ; Sang Rok LEE ; Sang Yup LIM ; Hyung Wook PARK ; Il Suk SOHN ; Kye Hun KIM ; Young Joon HONG ; Weon KIM ; Ju Han KIM ; Young Keun AHN ; Myung Ho JEONG ; Jeong Gwan CHO ; Jong Chun PARK ; Jung Chaee KANG ; Sei Jong KIM
Korean Journal of Medicine 2006;71(4):371-380
BACKGROUND: Atrial fibrillation (AF) is the most common cause of embolic cerebral infarction. This study was performed to determine new risk factors and the mechanism underlying thromboembolism (TE) in patients with AF. METHODS: 192 patients (M:F=137:55, 61+/-11 years) with AF were randomly selected and divided into a TE (n=95) and non-TE group (n=97). Another 71 patients with AF (M:F=38:33, 55+/-14) were studied for endothelial function by measuring the level of von Willebrand factor (vWF; factor 8 related antigen), inflammation by WBC, ESR, and high sensitive CRP and coagulation system by fibrinogen, fibrinogen degradation product and fibrin d-dimer; the results were compared with 25 patients with normal sinus rhythm. RESULTS: The TE group was older than non-TE group. Hypertension (HTN), diabetes mellitus (DM), hypercholesterolemia, smoking and fine AF (AF wave amplitude <1 mm) were more frequent in the TE group. Mitral valvular disease, an ejection fraction <40% and dilated cardiomyopathy were more frequent in the TE group and the left atrial (LA) dimension was greater in the TE group. The use of anticoagulants, an angiotensin-II receptor blocker and statins were less frequently observed in the TE group. The vWF-factor 8 related antigen was higher in patients with advanced age, LV dysfunction, HTN, DM, mitral stenosis and positively correlated with age, LA dimension, LV end-diastolic and end-systolic dimension, ejection fraction, NYHA class and AF duration. The fibrinogen level was positively correlated with age, NYHA class, LA dimension and d-dimer with NYHA class. Markers for inflammation or coagulation were not significantly different in the atrial fibrillation and the sinus rhythm group. CONCLUSIONS: No use of an angiotensin-II receptor blocker or statin and fine AF may be new risk factors for TE in patients with AF. The TE risk factors are thought to increase TE by impairing endothelial function.
Anticoagulants
;
Atrial Fibrillation*
;
Cardiomyopathy, Dilated
;
Cerebral Infarction
;
Diabetes Mellitus
;
Fibrin
;
Fibrinogen
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Hypercholesterolemia
;
Hypertension
;
Inflammation
;
Mitral Valve Stenosis
;
Risk Factors*
;
Smoke
;
Smoking
;
Thromboembolism
;
von Willebrand Factor